Filing Analysis
Cemtrex, Inc. completed the acquisition of substantially all assets of Plant Engineering Services, Inc. (PES) for $3.5 million in cash plus contingent earnouts. The company also reported significant share issuances via unregistered transactions following a recent reverse stock split.
🚩 Red Flags
- Recent history of a 1-for-10 reverse stock split (June 5, 2026).
- High volume of unregistered equity issuances (609,000 shares) relative to the current low float (~1.7M shares).
- Extremely low share count/float which increases volatility and susceptibility to manipulation.
📋 Key Facts
- Acquisition of PES assets completed on July 1, 2026, through subsidiary AIS Engineering, Inc.
- Purchase price: $3,500,000 in cash plus assumption of certain liabilities.
- Contingent earnout potential: up to $1,750,000 over three years based on gross profit targets.
- Post-reverse split share count (as of July 2, 2026): approximately 1,721,141 shares outstanding.
- Approximately 609,000 shares issued in unregistered transactions since the June 5, 2026, reverse split.
Cemtrex Inc. is implementing a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The split is scheduled to take effect on June 5, 2026.
🚩 Red Flags
- Internal inconsistency in the filing: The text explicitly mentions a '1-for-10' ratio in the first paragraph of Item 5.03, but repeatedly references a 'one-fifteenth' (1-for-15) reduction in the 'Effects' section.
- The split is being performed specifically to avoid delisting from the Nasdaq Capital Market (Rule 5550(a)(2)).
- Adjustable Warrants (3,975,653 shares at $0.75) contain a pricing reset mechanism that will significantly increase the number of shares issuable and reduce the exercise price post-split, creating potential massive dilution.
📋 Key Facts
- Reverse split ratio is stated as 1-for-10 in the introductory paragraph, but the 'Effects' section describes a reduction to one-fifteenth (1-for-15) of shares.
- Effective date is June 5, 2026, at 12:01 a.m. Eastern Time.
- Shares outstanding as of filing date: 11,121,834.
- New CUSIP number: 15130G865; Ticker 'CETX' remains unchanged.
- Fractional shares for holders of at least one whole share will be rounded up to the nearest whole share.
Cemtrex Inc. reported the results of its Annual Meeting held on May 15, 2026, where shareholders elected four directors and ratified the company's independent auditor. The results highlight a significant concentration of voting power held by the CEO.
🚩 Red Flags
- Extreme concentration of voting power: CEO Saagar Govil controls 86.6% of the total votes through Series C Preferred Stock, effectively rendering common shareholder votes immaterial on most matters.
- The company operates with a dual-class or multi-class voting structure that heavily favors the insider/founder.
📋 Key Facts
- Annual Meeting of Shareholders held on May 15, 2026.
- Total voting shares entitled to vote: 116,513,938.
- CEO Saagar Govil holds 100,881,671 votes via Series C Preferred Stock, representing approximately 86.6% of the total voting power.
- Common stock outstanding was 10,078,089 shares, representing only 8.6% of the total voting power.
- Four directors (Saagar Govil, Brian Kwon, Manpreet Singh, and Mitodi Filipov) were elected for one-year terms.
- Grassi Co. was ratified as the independent registered public accounting firm for the fiscal year ending September 30, 2026.
Cemtrex Inc. filed an amendment to a previous 8-K to provide required financial statements and proforma information following the acquisition of Invocon Inc. The company acquired 100% of Invocon for a cash payment of $7,060,000.
📋 Key Facts
- Acquisition of Invocon Inc. completed on January 8, 2026.
- Total purchase price was $7,060,000 paid in cash.
- The transaction involved 100% of the issued and outstanding shares of Invocon from seller Karl F. Kiefer.
- Invocon is now a wholly owned subsidiary of Cemtrex.
- This filing (8-K/A) provides audited financial statements for Invocon for the year ended December 31, 2024, and unaudited statements for the period ended September 30, 2025.
Cemtrex Inc. announced that its Board of Directors has resolved to pay the upcoming dividend on its Series 1 Preferred Stock in additional shares of the same stock rather than cash. The dividend, based on a 10% annual rate on a $10.00 preference amount, will be issued on April 7, 2026.
🚩 Red Flags
- Payment-in-kind (PIK) dividends are often used to preserve cash, suggesting potential liquidity constraints.
- Unregistered sales of equity securities (Item 3.02) result in dilution of existing preferred shareholders' equity base.
📋 Key Facts
- Board resolution passed on March 18, 2026, to pay dividends in-kind.
- Dividend rate is 10% annually, payable semiannually.
- Preference amount is $10.00 per share.
- Record date for the dividend is March 31, 2026.
- Issuance date for the new shares is April 7, 2026.
Cemtrex, Inc. completed a two-part acquisition on February 5, 2026, involving the purchase of substantially all assets of Richland Industries LLC and its primary operating facility in Tennessee.
🚩 Red Flags
- Significant increase in debt load via new mortgage ($3.92M) and note payable ($600k).
📋 Key Facts
- Acquired business assets of Richland Industries LLC for $600,000 via a note payable from Fulton Bank (6.09% interest, maturing Feb 1, 2031).
- Acquired real estate facility in Pulaski, Tennessee for $4,900,000.
- Real estate financing includes a $3,920,000 mortgage from Fulton Bank (SOFR + 2.75% interest, maturing Feb 1, 2041).
- The remaining real estate balance and closing costs were paid in cash.
- Richland's operations are integrated into the Company's Industrial Services Segment.
Cemtrex, Inc. completed a registered direct offering on January 9, 2026, raising $4,000,000 through the issuance of common stock and pre-funded warrants to an institutional investor.
🚩 Red Flags
- Potential dilution: The issuance of warrants for over 1 million shares represents significant potential future dilution for existing shareholders.
📋 Key Facts
- Total gross proceeds from the offering: $4,000,000.
- Securities issued include 400,000 shares of common stock and pre-funded warrants for 1,069,507 shares.
- The transaction was conducted via a registered direct offering to a single accredited institutional investor.
- The offering closed on January 9, 2026.
Cemtrex, Inc. has completed the acquisition of 100% of Invocon, Inc. for a total cash consideration of $7,060,000. As a result of this transaction, Invocon becomes a wholly-owned subsidiary of Cemtrex.
🚩 Red Flags
- Significant cash outlay ($7.06M) which may impact liquidity depending on the company's current cash position (not specified in this filing).
📋 Key Facts
- Acquisition date: January 8, 2026 (Closing).
- Target company: Invocon, Inc., a Texas corporation.
- Purchase price: $7,060,000 paid in cash.
- Structure: 100% of issued and outstanding shares acquired from Karl F. Kiefer.
- Financial statements for the business acquired will be filed via amendment within 71 days.
Cemtrex, Inc. entered into a Securities Purchase Agreement with an institutional investor for a registered direct offering totaling $2,000,000 in gross proceeds. The offering, which closed on December 23, 2025, consists of common stock and pre-funded warrants.
🚩 Red Flags
- Potential dilution: The issuance of nearly 550k warrant shares plus 340k common shares represents significant potential dilution for existing shareholders.
📋 Key Facts
- Total aggregate gross proceeds: $2,000,000
- Closing date: December 23, 2025
- Securities issued: 340,000 shares of common stock and pre-funded warrants to purchase 548,889 shares of common stock.
- The offering was conducted via a registered direct offering to a single accredited institutional investor.
Cemtrex, Inc. closed a registered direct offering on December 23, 2025, raising $2,000,000 in gross proceeds from a single accredited institutional investor through the issuance of common stock and pre-funded warrants.
🚩 Red Flags
- Concentration risk: The entire $2M raise is from a single institutional investor.
- Potential dilution: Issuance of common stock and warrants to purchase an additional 470,000 shares will dilute existing shareholders.
📋 Key Facts
- Total aggregate gross proceeds: $2,000,000
- Securities issued: 330,000 shares of common stock and pre-funded warrants to purchase 470,000 shares of common stock.
- The offering was conducted via a registered direct offering.
- Closing date: December 23, 2025.
- Investor type: Single accredited institutional investor.
Cemtrex, Inc. completed a registered direct offering on December 11, 2025, raising $2,000,000 in gross proceeds from a single accredited institutional investor through the issuance of common stock and pre-funded warrants.
🚩 Red Flags
- Potential dilution for existing shareholders due to the issuance of common stock and warrants totaling 666,667 potential shares.
📋 Key Facts
- Total aggregate gross proceeds: $2,000,000
- Securities issued: 310,000 shares of common stock and pre-funded warrants to purchase 356,667 shares of common stock.
- Offering type: Registered direct offering.
- Date of closing: December 11, 2025.
- Investor: Single accredited institutional investor.
Cemtrex Inc. issued over 2.5 million shares of common stock to satisfy $6.08 million in debt obligations and saw significant warrant exercises, including a $5.5 million cash inflow from Series B warrants.
🚩 Red Flags
- Significant equity dilution: The issuance of 2.5 million shares to satisfy debt represents approximately 38% of the total outstanding shares (6,217,047) as of Dec 10.
- Debt-for-equity swap indicates potential liquidity constraints or a preference for reducing debt via dilution rather than cash.
- Extreme volatility in share count: The issuance of ~2.5M shares against an outstanding float of ~6.2M suggests massive dilutive pressure on existing shareholders.
📋 Key Facts
- Issued 2,500,609 shares of common stock to lenders to satisfy $6,084,000 of debt on December 8, 2025.
- Exercised 9,981 Series A Warrants resulting in the issuance of 29,943 shares.
- Exercised 2,234,247 Series B Warrants resulting in the issuance of 2,234,247 shares.
- Received $5.5 million in cash proceeds from the exercise of Series B Warrants.
- Total common stock outstanding as of December 10, 2025, is 6,217,047 shares.
Cemtrex, Inc. has entered into a definitive agreement to acquire 100% of Invocon, Inc., a systems-engineering firm, for $7.06 million. The acquisition is expected to close around January 1, 2026, and will lead to the creation of a new Aerospace & Defense reporting segment.
📋 Key Facts
- Acquisition of 100% of issued and outstanding shares of Invocon, Inc.
- Purchase price is $7,060,000.
- Invocon is a systems-engineering firm specializing in aerospace, defense, and civil structure monitoring.
- Transaction expected to close on or around January 1, 2026.
- Cemtrex plans to establish a new 'Aerospace & Defense' reporting segment following the acquisition.
Cemtrex, Inc. entered into a $7.025 million promissory note with Streeterville Capital, LLC to fund potential acquisitions. The agreement includes significant punitive interest terms and a large one-time fee if not paid by year-end.
🚩 Red Flags
- High cost of capital: The $1.05 million one-time fee triggered on Jan 1, 2026, represents a massive effective interest spike (approx. 15% of principal) in a very short window.
- Debt structure suggests potential liquidity pressure or high urgency for the company to find acquisitions/cash flow quickly.
- The terms appear highly favorable to the lender (Streeterville Capital, LLC) and punitive toward the issuer.
📋 Key Facts
- Issued a Promissory Note on November 7, 2025, with an original principal amount of $7,025,000.
- Net cash received was $7,000,000 after $25,000 in issuance fees.
- Interest rate is SOFR until Dec 31, 2025; increases to 8% per annum starting Jan 1, 2026.
- A one-time additional interest fee of $1,050,000 will be added to the balance if outstanding on January 1, 2026.
- Note matures in 18 months with redemptions starting after 6 months.
- Proceeds are earmarked for potential acquisitions.
Cemtrex Inc. has approved a 1-for-15 reverse stock split effective September 29, 2025. The action is intended to boost the share price above $1.00 to maintain compliance with Nasdaq listing requirements.
🚩 Red Flags
- Reverse stock split is often viewed by markets as a sign of distress or impending delisting.
- The company is facing Nasdaq non-compliance regarding its minimum bid price ($1.00 requirement).
- Significant dilution/adjustment risk: The 'Adjustable Warrants' provision allows for a potential significant increase in the number of shares issuable, which can lead to massive dilution for existing common shareholders.
📋 Key Facts
- Reverse split ratio: 1-for-15.
- Effective date/time: September 29, 2025, at 12:01 a.m. ET.
- Reason for split: To regain compliance with Nasdaq Listing Rule 5550(a)(2) regarding minimum bid price requirements.
- Shares outstanding prior to split: 11,084,809 shares.
- New CUSIP number: 15130G873.
- Adjustable Warrants: Holders of 15,412,956 warrants will see their exercise price reduced to the lowest VWAP over a 10-day window (5 days pre-split and 5 days post-split), with an increase in the number of shares issuable.
Cemtrex, Inc. announced a resolution to pay dividends on its Series 1 Preferred Stock in the form of additional shares of Series 1 Preferred Stock rather than cash.
🚩 Red Flags
- Dividend paid in stock rather than cash suggests potential liquidity constraints or a desire to preserve cash reserves.
📋 Key Facts
- Dividend payment method: Additional shares of Series 1 Preferred Stock (stock dividend).
- Dividend rate: 10% annually based on a $10.00 per share Preference Amount, payable semiannually.
- Record date for dividend: September 30, 2025.
- Payment date: October 7, 2025.
Cemtrex Inc. has successfully regained compliance with Nasdaq's minimum stockholder's equity requirement. Following a period of non-compliance, the company's March 31, 2025, financial statements show sufficient equity to resolve the delisting threat.
🚩 Red Flags
- Historical breach of minimum equity requirements (under $2.5M)
- Previous risk of delisting from Nasdaq Capital Market
📋 Key Facts
- Company was previously in violation of Nasdaq Marketplace Rule 5550(b)(1) due to stockholder's equity falling below $2,500,000 as of Dec 31, 2024.
- Nasdaq had granted an extension to August 20, 2025, to regain compliance.
- As of the March 31, 2025, Form 10-Q filing, stockholder's equity was reported at $6,403,022.
- Nasdaq notified the company on June 4, 2025, that it is now in compliance and the delisting matter is closed.
Cemtrex Inc. has closed the exercise of an over-allotment option by Aegis Capital Corp., resulting in the sale of 187,500 additional shares at $1.00 per share.
🚩 Red Flags
- Dilutive event: The issuance of additional common stock dilutes existing shareholders.
- Low share price: Offering shares at $1.00 per share is characteristic of micro-cap companies seeking immediate liquidity.
📋 Key Facts
- The Underwriter (Aegis Capital Corp.) fully exercised its 45-day over-allotment option on June 2, 2025.
- The offering involved the sale of 187,500 'Option Shares' at a price of $1.00 per share.
- Aggregate gross proceeds from this specific portion of the offering are approximately $187,500 (before discounts and expenses).
- This follows an initial firm commitment public offering of 1,250,000 shares reported on May 29, 2025.
Cemtrex Inc. announced the closing of an over-allotment option related to a previous public offering. The Underwriter, Aegis Capital Corp., fully exercised its option to purchase additional shares.
🚩 Red Flags
- Dilutive event: The issuance of new common stock dilutes existing shareholders.
- Low offering price: Shares were priced at $1.00, which is often a sign of capital necessity in micro-cap companies.
📋 Key Facts
- Underwriter (Aegis Capital Corp.) fully exercised its 45-day over-allotment option on June 2, 2025.
- The offering involved the sale of up to 187,500 additional shares of common stock.
- The exercise resulted in aggregate gross proceeds of approximately $187,500 (before discounts and expenses).
- This follows a primary firm commitment offering of 1,250,000 shares at $1.00 per share announced on May 29, 2025.
Cemtrex Inc. entered into an underwriting agreement with Aegis Capital Corp. for a firm commitment public offering of 1,250,000 common shares at $1.00 per share. The offering closed on May 29, 2025, raising approximately $1.25 million in gross proceeds.
🚩 Red Flags
- Dilutive offering at a low share price ($1.00).
- Small capital raise relative to typical micro-cap operational needs, suggesting potential liquidity constraints or continuous need for financing.
📋 Key Facts
- Underwriter: Aegis Capital Corp.
- Offering Size: 1,250,000 firm shares plus an over-allotment option of up to 187,500 shares.
- Price per Share: $1.00
- Gross Proceeds: Approximately $1,250,000 (before expenses).
- Closing Date: May 29, 2025.
- Registration Basis: Shelf registration statement on Form S-3 (File No. 333-283995) effective Feb 3, 2025.
Cemtrex Inc. held its Annual Meeting of Shareholders on May 16, 2025. The meeting resulted in the election of four directors and the ratification of Grassi Co. Certified Public Accountants as the company's independent auditor.
🚩 Red Flags
- High concentration of voting power: CEO Saagar Govil holds a significant portion of the total voting shares (including Series A and C Preferred Stock).
📋 Key Facts
- Annual Meeting held on May 16, 2025.
- Quorum reached was 89.5% (22,088,218 voting shares represented).
- Four nominees—Saagar Govil, Brian Kwon, Manpreet Singh, and Mitodi Filipov—were elected to the Board of Directors.
- Proposal 2: Ratification of Grassi Co. Certified Public Accountants as independent auditors for fiscal year ending Sept 30, 2024, was approved with 22,011,352 votes in favor.
Cemtrex Inc. has received an extension from Nasdaq to regain compliance with the minimum stockholder's equity requirement of $2,500,000. The company must demonstrate compliance through a specific transaction or event by August 20, 2025.
🚩 Red Flags
- Delisting notice/Non-compliance with Nasdaq listing rules (Rule 5550(b)(1))
- Stockholder's equity is below the $2.5M minimum threshold
- Risk of delisting remains if compliance is not met by the next periodic report or the September 30, 2025, 10-K filing.
📋 Key Facts
- The company fell below the $2,500,000 minimum stockholder's equity requirement as of Dec 31, 2024.
- Nasdaq granted an extension to regain compliance with a deadline of August 20, 2025.
- Compliance must be evidenced via one of two alternatives: a report detailing a specific transaction that restored equity, or a pro forma balance sheet showing compliance.
- Failure to evidence compliance by the filing of the Form 10-K for the period ending September 30, 2025, may result in delisting.
Cemtrex, Inc. announced a resolution to pay dividends on its Series 1 Preferred Stock using additional shares of Series 1 Preferred Stock instead of cash.
🚩 Red Flags
- Dividend paid in stock rather than cash may indicate liquidity constraints or a desire to preserve cash reserves.
📋 Key Facts
- Dividend payment method: Additional shares of Series 1 Preferred Stock (stock dividend).
- Dividend rate: 10% annually based on a $10.00 per share Preference Amount, payable semiannually.
- Record date for holders: Close of business on March 31, 2025.
- Payment date: April 7, 2025.
Cemtrex, Inc. received a notification from Nasdaq stating it is in violation of the minimum stockholder's equity requirement ($2.5M) as of December 31, 2024. The company has until April 7, 2025, to submit a compliance plan.
🚩 Red Flags
- Delisting notice from Nasdaq
- Failure to meet minimum stockholder's equity requirement ($2.5M threshold)
- Potential for additional delisting risk regarding the Minimum Bid Price Requirement (implied in text)
📋 Key Facts
- Received Nasdaq notification on February 21, 2025.
- Violation of Nasdaq Marketplace Rule 5550(b)(1) regarding minimum stockholder's equity.
- Stockholder's equity was below $2,500,000 as reported in the 10-Q for period ended Dec 31, 2024.
- The company has 45 days (until April 7, 2025) to submit a plan to regain compliance.
- If a plan is accepted, an extension of up to 180 days may be granted (until August 20, 2025) to evidence compliance.
Cemtrex, Inc. announced the appointment of Paul J. Wyckoff as the company's new Chief Financial Officer, effective January 6, 2025.
📋 Key Facts
- Paul J. Wyckoff appointed as CFO on January 6, 2025.
- Mr. Wyckoff has served as Interim CFO since January 2022.
- He joined the company in March 2014 as Manager of Financial Reporting.
- Prior experience includes serving as Controller at Vaso Corporation.
Cemtrex Inc. has regained compliance with Nasdaq's minimum stockholder's equity requirement. Following a period of non-compliance, the company's Form 10-K filed on December 30, 2024, demonstrated sufficient equity to satisfy listing standards.
🚩 Red Flags
- Historical non-compliance with Nasdaq minimum stockholder's equity requirements (previously below $2.5M).
📋 Key Facts
- Company reported stockholders' equity of $4,710,677 in its Form 10-K filed on December 30, 2024.
- Nasdaq requirement for minimum stockholder's equity is $2,500,000 per Rule 5550(b)(1).
- The company was previously granted an extension to February 17, 2025, to regain compliance.
- Nasdaq notified the company on January 2, 2025, that the matter regarding delisting due to equity deficiency is now closed.
Cemtrex, Inc. has received notification from Nasdaq confirming it has regained compliance with the minimum bid price requirements under Listing Rule 5550(a)(2). The company's common stock will continue to be listed and traded on the Nasdaq Capital Market.
🚩 Red Flags
- Previous non-compliance with minimum bid price requirements indicates historical volatility or depressed stock price.
📋 Key Facts
- Notification date: December 11, 2024
- Compliance achieved for minimum bid price requirements (Nasdaq Listing Rule 5550(a)(2))
- The company's security will continue to be listed on the Nasdaq Capital Market
Cemtrex Inc. completed a 1-for-35 reverse stock split effective after the close of business on November 25, 2024. The filing details the resulting share structure and adjusted warrant pricing.
🚩 Red Flags
- Reverse stock split (typically used to combat delisting or low share prices).
- Extremely low float: Only 1,338,608 shares of common stock are currently issued and outstanding as of Dec 4, 2024.
📋 Key Facts
- Completed a one-for-thirty-five (1-for-35) reverse stock split.
- Effective date: After close of business on November 25, 2024.
- As of December 4, 2024, outstanding common stock is reduced to 1,338,608 shares.
- Outstanding warrants include 90,822 Series A Warrants and 3,652,206 Series B Warrants.
- Adjusted exercise price for warrants is $3.1488 per share.
Cemtrex Inc. has approved a 1-for-35 reverse stock split effective November 26, 2024, to regain compliance with Nasdaq's minimum bid price requirement.
🚩 Red Flags
- Reverse stock split (Red flag escalator).
- Delisting risk: Company is currently in violation of Nasdaq's minimum bid price requirement.
- Dilution/Anti-dilution complexity: The 'Adjustable Warrants' clause will result in a significant increase in the number of shares issuable, potentially causing massive dilution to existing shareholders.
📋 Key Facts
- Reverse split ratio is 1-for-35.
- Effective date: November 26, 2024, at 12:01 a.m. ET.
- Purpose: To address Nasdaq non-compliance regarding the $1 minimum bid price rule (Nasdaq Listing Rule 5550(a)(2)).
- The company received a deficiency notice on June 14, 2024, with a compliance deadline of December 11, 2024.
- CUSIP number will change to 15130G881; trading symbol 'CETX' remains unchanged.
- Adjustable Warrants (19,026,954 shares) feature a price-reset mechanism that will significantly increase the number of underlying shares post-split.
Cemtrex Inc. has received an extension from Nasdaq to regain compliance with the minimum stockholder's equity requirement. The company must demonstrate compliance via a specific transaction or pro forma balance sheet by February 17, 2025.
🚩 Red Flags
- Delisting notice regarding minimum stockholder's equity requirement.
- Existing deficiency regarding minimum bid price ($1.00/share) previously reported on June 14, 2024.
- Potential for delisting if compliance is not met by the March 31, 2025 reporting period.
📋 Key Facts
- Nasdaq notified the company that stockholder's equity fell below $2,500,000 as of June 30, 2024 (per Form 10-Q).
- The company previously received a deficiency notice regarding the minimum bid price requirement ($1.00/share) on June 14, 2024.
- On October 23, 2024, Nasdaq granted an extension to regain compliance with the Minimum Stockholder’s Equity Requirement.
- Compliance must be evidenced by February 17, 2025, through either a disclosure of a qualifying transaction (Alternative 1) or a pro forma balance sheet showing compliance (Alternative 2).
- Failure to evidence compliance by the March 31, 2025, periodic report filing may result in delisting.
Cemtrex Inc. has completed a 1-for-60 reverse stock split effective October 3, 2024. The filing provides updated share counts and adjusted warrant exercise prices following the consolidation.
🚩 Red Flags
- Reverse stock split (often used to combat delisting or maintain minimum bid requirements).
- Significant dilution/restructuring of capital structure via the 1-for-60 ratio.
📋 Key Facts
- Completed a one-for-sixty (1-for-60) reverse stock split of common stock.
- Effective date of the split was after the close of business on October 3, 2024.
- As of October 15, 2024, there are 25,586,668 shares of common stock issued and outstanding.
- Outstanding warrants include 1,441,927 Series A Warrants and 15,444,532 Series B Warrants.
- The adjusted exercise price per share for all outstanding warrants is $0.7446.
Cemtrex Inc. has approved a 1-for-60 reverse stock split effective October 3, 2024. The primary purpose of this action is to regain compliance with Nasdaq's minimum bid price requirement ($1.00) following a period of non-compliance.
🚩 Red Flags
- Reverse stock split (often a sign of extreme distress/low share price).
- Nasdaq delisting risk: The company is currently under deficiency notice and must maintain the $1 minimum for 10 consecutive business days to regain compliance.
- Adjustable Warrants provision: Existing warrants contain an anti-dilution adjustment that will significantly increase the number of shares issuable at a potentially much lower exercise price, leading to massive dilution.
📋 Key Facts
- Reverse split ratio: 1-for-60.
- Effective date/time: October 3, 2024, at 12:01 a.m. ET.
- Purpose: To regain compliance with Nasdaq Listing Rule 5550(a)(2) regarding the $1 minimum bid price requirement.
- The company received a Nasdaq deficiency notice on June 14, 2024.
- CUSIP number will change to 15130G808; ticker symbol 'CETX' remains unchanged.
- Fractional shares will be rounded up to one whole share; no cash in lieu of fractional shares will be paid.
Cemtrex, Inc. announced a resolution to pay dividends on its Series 1 Preferred Stock in the form of additional shares of Series 1 Preferred Stock. The dividend is scheduled to be issued on October 7, 2024.
🚩 Red Flags
- Dividend paid in stock rather than cash may indicate liquidity constraints or a desire to preserve cash reserves.
📋 Key Facts
- Dividend type: Payment in additional shares of Series 1 Preferred Stock (stock dividend).
- Dividend rate: 10% annually based on a $10.00 per share Preference Amount.
- Payment frequency: Payable semiannually.
- Record date: Close of business on September 30, 2024.
- Distribution date: October 7, 2024.
Cemtrex Inc. received a notification from Nasdaq stating it is in non-compliance with the minimum stockholder's equity requirement ($2,500,000) as of June 30, 2024. This follows a previous notice regarding failure to meet the minimum bid price requirement.
🚩 Red Flags
- Delisting notice for minimum stockholder's equity
- Existing delisting notice for minimum bid price requirement (multiple non-compliance issues)
- Potential for significant dilution if a reverse stock split is used to regain bid price compliance
- Low equity position ($< $2.5M) indicates potential liquidity or solvency concerns
📋 Key Facts
- Received Nasdaq notification on August 21, 2024, for failing the Minimum Stockholder’s Equity Requirement (Nasdaq Marketplace Rule 5550(b)(1)).
- Stockholder's equity was below $2,500,000 as reported in the Form 10-Q for the period ended June 30, 2024.
- The company is already under a separate notice (received June 14, 2024) for failing the Minimum Bid Price Requirement ($1.00 per share).
- The company has until October 7, 2024, to submit a plan to regain compliance.
- If a plan is accepted, the company may have an extension until February 18, 2025, to evidence compliance with equity requirements.
Cemtrex Inc. has amended its Certificate of Incorporation to increase the number of authorized common shares from 50,000,000 to 70,000,000 via stockholder written consent.
🚩 Red Flags
- Increase in authorized share count often precedes a dilutive equity offering or warrants exercise to raise capital.
📋 Key Facts
- Board and a majority of issued/outstanding voting stock approved the amendment by written consent.
- Authorized Common Stock increased from 50,000,000 shares to 70,000,000 shares.
- The increase was effective upon filing with the Secretary of State of Delaware on August 2, 2024.
- Newly authorized shares have identical rights to currently outstanding Common Stock.
Cemtrex, Inc. received a notification from Nasdaq stating it is in violation of the minimum bid price requirement after its stock closed below $1.00 for 30 consecutive trading days. The company has until December 11, 2024, to regain compliance.
🚩 Red Flags
- Delisting notice from Nasdaq
- Potential requirement for a reverse stock split to regain compliance
- Prolonged period of sub-$1.00 trading (30+ consecutive days)
📋 Key Facts
- Received Nasdaq notification on June 14, 2024.
- Violation of Nasdaq Marketplace Rule 5550(a)(2) due to closing bid price below $1.00 for 30 consecutive trading days.
- The company has a 180-day compliance period ending December 11, 2024.
- Compliance can be achieved if the stock closes at or above $1.00 for 10 consecutive business days.
- A second 180-day extension may be available if the company meets market value requirements and intends to cure via a reverse stock split.
Cemtrex Inc. held its Annual Meeting of Shareholders on May 16, 2024. The meeting resulted in the election of four directors and the ratification of Grassi Co. as the company's independent registered public accounting firm.
🚩 Red Flags
- Concentrated voting control: CEO Saagar Govil controls the vast majority of voting shares through preferred stock structures, which can limit minority shareholder influence.
📋 Key Facts
- Annual Meeting held on May 16, 2024.
- Quorum was established with 14,016,827 voting shares represented (86.7% of total voting shares).
- Four nominees (Saagar Govil, Brian Kwon, Manpreet Singh, and Mitodi Filipov) were elected to the Board of Directors.
- Proposal 2 was approved: Grassi Co. Certified Public Accountants ratified as independent auditors for the fiscal year ending September 30, 2024.
- Saagar Govil (CEO/Chairman) holds a significant majority of voting power via Series 1 and Series C Preferred Stock.
Cemtrex, Inc. completed a public offering of units and pre-funded warrants totaling approximately $10 million in gross proceeds. The offering includes highly dilutive warrant terms, including a 3x multiplier for cashless exercise and price reset provisions linked to future reverse stock splits.
🚩 Red Flags
- Highly dilutive warrant structures (3x multiplier on cashless exercise).
- Warrant price reset provisions specifically tied to future reverse stock splits, suggesting potential upcoming dilution/splits.
- Significant issuance of pre-funded warrants which can lead to massive share overhang.
📋 Key Facts
- Closed the offering on May 3, 2024.
- Total aggregate gross proceeds: approximately $10,035,000.
- Sold 554,705 Common Units and 11,210,000 Pre-funded Units.
- Series A Warrants include an alternative cashless exercise option that allows holders to receive three times the number of shares as a cash exercise.
- Warrants contain price reset provisions triggered by a future reverse stock split or issuance of common stock at prices below current levels.
- Underwriter (Aegis Capital Corp.) received a 7.0% discount plus expense reimbursements.
Cemtrex, Inc. entered into a Standstill Agreement with Streeterville Capital, LLC to prevent the redemption of two outstanding notes. The agreement involves extending note maturities in exchange for significant cash payments or equity participation.
🚩 Red Flags
- High cost of capital/liquidity preservation: The company is paying up to 50% of gross financing proceeds to a creditor, which is highly dilutive and expensive.
- Urgent liquidity pressure: The requirement to secure financing by May 10, 2024 (only 10 days from the filing) indicates an imminent need for cash.
- Debt restructuring/Extension: Extending maturities on existing debt often signals difficulty in meeting original repayment obligations.
📋 Key Facts
- Entered into a Standstill Agreement with Streeterville Capital, LLC on April 30, 2024.
- Streeterville agreed not to redeem its two outstanding notes (dated Sept 20, 2021 and Feb 22, 2022) for one year.
- Maturity dates of the notes are extended to June 30, 2025, and February 22, 2026, respectively.
- Condition: The Company must engage in a financing on or before May 10, 2024.
- Payment Terms: Company must pay Streeterville the greater of $4 million or 50% of net proceeds from any sale of common or preferred stock during the Standstill Period.
Cemtrex Inc. announced a resolution to pay dividends on its Series 1 Preferred Stock in the form of additional shares of Series 1 Preferred Stock rather than cash.
🚩 Red Flags
- Dividend paid in stock rather than cash often suggests liquidity constraints or a desire to preserve cash reserves.
- The Series 1 Preferred Stock ticker (CETXP) is noted as 'Suspended'.
📋 Key Facts
- Dividend payment date: April 5, 2024
- Record date: Close of business on March 29, 2024
- Dividend rate: 10% annually based on a $10.00 per share Preference Amount
- Payment method: Additional shares of Series 1 Preferred Stock (stock dividend)
- Series 1 Preferred Stock trading symbol is currently listed as 'CETXP' (Suspended)
Cemtrex Inc. has received a notice from the Nasdaq Hearings Panel to delist its Series 1 Preferred Stock (CETXP) effective January 22, 2024. This follows the company's failure to meet terms of an exception previously granted on September 8, 2023.
🚩 Red Flags
- Delisting notice for Series 1 Preferred Stock (CETXP).
- Failure to comply with Nasdaq's previous compliance exception/reinstatement terms.
- Imminent suspension of trading for the preferred security.
📋 Key Facts
- Nasdaq Hearings Panel determined to delist Series 1 Preferred Stock (CETXP).
- The delisting is due to failure to satisfy the terms of a previous exception granted on September 8, 2023.
- Trading suspension for CETXP is effective at the open of business on January 22, 2024.
- The notice was received by the company on January 18, 2024.
Cemtrex Inc. reports a failed special meeting of Series 1 Preferred Stockholders due to lack of quorum and received amended delisting exceptions from Nasdaq. The company is considering share repurchases to meet the $1 minimum bid price requirement by January 8, 2024.
🚩 Red Flags
- Delisting notice/Nasdaq Hearings Panel involvement
- Failure to reach quorum at a special meeting (indicates shareholder apathy or lack of engagement)
- Urgent deadline for minimum bid price compliance (Jan 8, 2024)
- Potential use of cash for share repurchases to artificially meet listing requirements
📋 Key Facts
- Special Meeting of Series 1 Preferred Stockholders on Dec 29, 2023, failed to reach a quorum; resolution did not pass.
- Nasdaq Hearings Panel amended exceptions on Jan 3, 2024.
- Series 1 Preferred Stock must close at $\ge$ $1.00 for 10 consecutive business days starting January 8, 2024.
- Company must demonstrate compliance with Listing Rule 5555(a)(1) by January 22, 2024.
- Management is considering using the August 22, 2023 Share Repurchase Program to support the stock price.